Paul Moayyedi

33PUBLICATIONS
223CO-AUTHORS
Innate immunityGene expression (incl. microarray and other genome-wide approaches)Cancer therapy (excl. chemotherapy and radiation therapy)Te mātauranga kura tuarua Māori (Māori secondary education)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (33)

|Jul 08, 2026
Phage intervention improves colitis and response to corticosteroids by attenuating virulence of Crohn's disease-associated bacteria.

|May 25, 2026
Exome sequencing directly implicates 68 genes in inflammatory bowel disease.

|Dec 10, 2025
Combination Therapy With Fecal Microbiota Transplantation and Vedolizumab for Induction of Remission in Ulcerative Colitis: An Open-Label Pilot Study.

Saad Syed, Paul Moayyedi, Dina Kao

|Oct 17, 2025
Response to Maximilian and Gasche.

Eamonn M M Quigley, Purna Kashyap, Paul Moayyedi

|Sep 05, 2025
Metabolomics reveal distinct molecular pathways associated with future risk of Crohn's Disease.

Mingyue Xue, Sun-Ho Lee, Jingchen Shao

|Aug 04, 2025
Ultraprocessed Grains and Risk of Inflammatory Bowel Disease: Results From the Prospective Urban Rural Epidemiology Study.

Neeraj Narula, Emily C L Wong, Andrew Mente

Pageof 6

Frequent Collaborators

6 joint publications

Deborah A Marshall

5 joint publications

David Armstrong

4 joint publications

Neeraj Narula

4 joint publications

Alexander C Ford